• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Pacira Pharmaceuticals, Inc. (PCRX)

    -NasdaqGS
    85.07 Up 0.80(0.95%) Apr 24, 4:00PM EDT
    |After Hours : 84.56 Down 0.51 (0.60%) Apr 24, 4:10PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 61,792   52,048   47,166   36,662  
    Cost of Revenue18,968  20,391  19,954  18,127  
    Gross Profit 42,824   31,657   27,212   18,535  
    Operating Expenses
    Research Development3,887  4,424  5,216  5,204  
    Selling General and Administrative31,019  28,217  24,837  22,589  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 7,918   (984) (2,841) (9,258)
    Income from Continuing Operations
    Total Other Income/Expenses Net113  17  (118)(112)
    Earnings Before Interest And Taxes8,031  (967)(2,959)(9,370)
    Interest Expense2,056  2,037  2,078  2,107  
    Income Before Tax5,975  (3,004)(5,037)(11,477)
    Income Tax Expense173   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops5,802  (3,004)(5,037)(11,477)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 5,802   (3,004) (5,037) (11,477)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 5,802   (3,004) (5,037) (11,477)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.